ZIOPHARM (ATI001-103): A Phase I Study of Ad-RTS-hIL-12, an Inducible Adenoviral Vector Engineered to Express hIL-12 in the Presence of the Activator Ligand Veledimex in Pediatric Brain Tumor Subjects

  • Goldman, Stewart (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date9/1/178/31/50

Funding

  • ZIOPHARM Oncology, Inc.